JPH11322713A5 - - Google Patents

Info

Publication number
JPH11322713A5
JPH11322713A5 JP1999109629A JP10962999A JPH11322713A5 JP H11322713 A5 JPH11322713 A5 JP H11322713A5 JP 1999109629 A JP1999109629 A JP 1999109629A JP 10962999 A JP10962999 A JP 10962999A JP H11322713 A5 JPH11322713 A5 JP H11322713A5
Authority
JP
Japan
Prior art keywords
methyl
oxyacetic acid
carbamoylcarbazol
compound
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP1999109629A
Other languages
English (en)
Japanese (ja)
Other versions
JPH11322713A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JPH11322713A publication Critical patent/JPH11322713A/ja
Publication of JPH11322713A5 publication Critical patent/JPH11322713A5/ja
Withdrawn legal-status Critical Current

Links

JP11109629A 1998-04-17 1999-04-16 置換三環式化合物 Withdrawn JPH11322713A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6232898A 1998-04-17 1998-04-17
US09/062328 1998-04-17

Publications (2)

Publication Number Publication Date
JPH11322713A JPH11322713A (ja) 1999-11-24
JPH11322713A5 true JPH11322713A5 (enExample) 2007-04-05

Family

ID=22041763

Family Applications (2)

Application Number Title Priority Date Filing Date
JP15240099A Expired - Fee Related JP4435330B2 (ja) 1998-04-17 1999-04-16 置換された三環式化合物
JP11109629A Withdrawn JPH11322713A (ja) 1998-04-17 1999-04-16 置換三環式化合物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP15240099A Expired - Fee Related JP4435330B2 (ja) 1998-04-17 1999-04-16 置換された三環式化合物

Country Status (30)

Country Link
EP (2) EP0950657B1 (enExample)
JP (2) JP4435330B2 (enExample)
KR (2) KR100586761B1 (enExample)
CN (1) CN1149193C (enExample)
AR (2) AR018593A1 (enExample)
AT (2) ATE271037T1 (enExample)
AU (2) AU753547B2 (enExample)
BR (2) BR9902365A (enExample)
CA (2) CA2269246C (enExample)
CO (2) CO5031247A1 (enExample)
CZ (2) CZ136999A3 (enExample)
DE (2) DE69917833T2 (enExample)
DK (1) DK0950657T3 (enExample)
DZ (1) DZ2769A1 (enExample)
EA (2) EA002347B1 (enExample)
ES (2) ES2222663T3 (enExample)
HU (2) HUP9901220A3 (enExample)
ID (2) ID23287A (enExample)
IL (2) IL129483A0 (enExample)
NO (2) NO314400B1 (enExample)
NZ (3) NZ507564A (enExample)
PE (2) PE20000476A1 (enExample)
PL (2) PL332566A1 (enExample)
PT (1) PT950657E (enExample)
SG (2) SG81976A1 (enExample)
SI (1) SI0950657T1 (enExample)
TR (2) TR199900843A2 (enExample)
TW (1) TWI238160B (enExample)
YU (2) YU19199A (enExample)
ZA (2) ZA992771B (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2301586A1 (en) * 1997-08-28 1999-03-04 William Louis Macias Method for treatment of non-rheumatoid arthritis
DZ2769A1 (fr) * 1998-04-17 2003-12-01 Lilly Co Eli Composés tricycliques substitués.
AU1940800A (en) * 1998-12-21 2000-07-12 Eli Lilly And Company Combination therapy for the treatment of sepsis
CA2379208A1 (en) * 1999-07-19 2001-01-25 Eli Lilly & Company Spla2 inhibitors
US6706752B1 (en) 1999-07-19 2004-03-16 Eli Lilly And Company sPLA2 inhibitors
AU2001267826A1 (en) * 2000-06-29 2002-01-08 Shionogi And Co., Ltd. Remedies for alzheimer's disease
WO2002000256A1 (fr) * 2000-06-29 2002-01-03 Shionogi & Co., Ltd. Remedes contre la cirrhose
WO2002000255A1 (en) * 2000-06-29 2002-01-03 Shionogi & Co., Ltd. Remedies for cancer
EP1303262A2 (en) * 2000-07-14 2003-04-23 Eli Lilly And Company Use of a spla2 inhibitor for the treatment of sepsis
US6872743B2 (en) 2000-12-18 2005-03-29 Eli Lilly And Company sPLA2 inhibitors
US6933313B2 (en) 2001-03-28 2005-08-23 Eli Lilly And Company Substituted carbazoles as inhibitors of sPLA2
AUPS282602A0 (en) 2002-06-07 2002-06-27 Garvan Institute Of Medical Research Method of inhibiting cell proliferation
DE10249055A1 (de) 2002-10-22 2004-05-06 Bayer Cropscience Ag 2-Phenyl-2-substituierte-1,3-diketone
JO3598B1 (ar) 2006-10-10 2020-07-05 Infinity Discovery Inc الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
EP1988098A1 (en) * 2007-04-27 2008-11-05 AEterna Zentaris GmbH Novel Tetrahydrocarbazole Derivatives as Ligands of G-protein Coupled Receptors
CA2719721C (en) 2008-03-26 2012-12-18 Daiichi Sankyo Company, Limited Tetrahydroisoquinoline derivative
AU2009233711B2 (en) 2008-04-09 2015-02-12 Infinity Pharmaceuticals, Inc Inhibitors of fatty acid amide hydrolase
US8580795B2 (en) 2009-01-22 2013-11-12 Orchid Chemicals & Pharmaceuticals Limited Heterocyclic compounds as phosphodiesterase inhibitors
WO2010118159A1 (en) 2009-04-07 2010-10-14 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
EP2416660B1 (en) 2009-04-07 2014-07-02 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
EP2531511A1 (en) 2010-02-03 2012-12-12 Infinity Pharmaceuticals, Inc. Fatty acid amide hydrolase inhibitors
AR088377A1 (es) 2011-10-20 2014-05-28 Siena Biotech Spa Proceso para la preparacion de 6-cloro-2,3,4,9-tetrahidro-1h-carbazol-1-carboxamida y compuestos intermedios de esta
CN102816107B (zh) * 2012-08-20 2015-06-03 东南大学 咔唑衍生物及其制备方法与用途
CN104797559A (zh) * 2012-11-30 2015-07-22 通用电气健康护理有限公司 卤化锌介导的环化过程得到三环吲哚
CN111362863A (zh) 2012-11-30 2020-07-03 通用电气健康护理有限公司 三环吲哚衍生物的结晶方法
EP3248230B1 (de) * 2015-01-20 2020-05-06 cynora GmbH Verwendung organischer moleküle in optoelektronischen bauelementen
CN108707104A (zh) * 2018-08-07 2018-10-26 北京恒信卓元科技有限公司 2-氯-1h-咔唑-1,4(9h)-二酮的合成方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3579534A (en) * 1969-05-09 1971-05-18 American Cyanamid Co Tetrahydrocarbazolecarboxylates
US3979391A (en) * 1972-11-22 1976-09-07 Sterling Drug Inc. 1,2,3,4-Tetrahydrocarbazoles
US3939177A (en) * 1972-11-22 1976-02-17 Sterling Drug Inc. 4-Aminomethyl-9-benzyl-1,2,3,4-tetrahydrocarbazoles
US5420289A (en) * 1989-10-27 1995-05-30 American Home Products Corporation Substituted indole-, indene-, pyranoindole- and tetrahydrocarbazole-alkanoic acid derivatives as inhibitors of PLA2 and lipoxygenase
PT95692A (pt) * 1989-10-27 1991-09-13 American Home Prod Processo para a preparacao de derivados de acidos indole-,indeno-,piranoindole- e tetra-hidrocarbazole-alcanoicos, ou quais sao uteis como inibidores de pla2 e da lipoxigenase
WO1993001169A2 (en) * 1991-07-05 1993-01-21 Merck Sharp & Dohme Limited Aromatic compounds, pharmaceutical compositions containing them and their use in therapy
MY110227A (en) * 1991-08-12 1998-03-31 Ciba Geigy Ag 1-acylpiperindine compounds.
IL109309A (en) * 1993-04-16 2000-06-29 Lilly Co Eli 1-H-indole-3-acetic acid hydrazide SPLA2 inhibitors and pharmaceutical compositions containing them
IL109311A0 (en) * 1993-04-16 1994-07-31 Lilly Co Eli 1H-indole-3-acetamide sPla2 inhibitors
CA2179678A1 (en) * 1995-06-23 1996-12-24 Michael Edward Flaugh 6-substituted-1,2,3,4-tetrahydro-9h-carbazoles and 7-substituted-10h-cyclohepta¬7,6-b| indoles
US6160175A (en) * 1995-12-13 2000-12-12 Eli Lilly And Company Naphthyl acetamides as sPLA2 inhibitors
KR20000049210A (ko) * 1996-10-30 2000-07-25 피터 지. 스트링거 치환된 트리시클릭류
CA2304482A1 (en) * 1997-09-26 1999-04-08 Eli Lilly And Company Method for the treatment of cystic fibrosis
CA2310250A1 (en) * 1997-11-14 1999-05-27 August Masaru Watanabe Treatment for alzheimer's disease
DZ2769A1 (fr) * 1998-04-17 2003-12-01 Lilly Co Eli Composés tricycliques substitués.

Similar Documents

Publication Publication Date Title
JP2000026416A5 (enExample)
AU2008246195B2 (en) Methods of Reducing Nephrotoxicity in Subjects Administered with Nucleoside Phosphonates
US6767900B2 (en) Phosphonate nucleotide compound
JPH11322745A5 (enExample)
KR100384262B1 (ko) 3,7-디티아프로스탄산 유도체
RU95118285A (ru) N-алкил-2-замещенные атф и его аналоги
EP1484059A3 (en) Antiviral composition comprising phenylacetic acid derivatives
KR920002622A (ko) 9-푸리닐 포스폰산 유도체
IE54423B1 (en) Combination of 2-substituted penems with dipeptidase inhibitors
JP2002521334A5 (enExample)
RU99112115A (ru) Энантиомерно чистые основные эфиры арил-циклоалкилгидроксикарбоновых кислот, способ их получения и применение в лекарственных средствах
JP2008523098A5 (enExample)
JP2004514663A5 (enExample)
JP2009525976A (ja) ビスホスホネート及び葉酸代謝拮抗剤を含む組成物
JP2005539045A5 (enExample)
JP2009532491A (ja) プロスタグランジンｅｐ４作用薬
IL115746A (en) Polyanionic benzylglcosides and pharmaceutical compositions containing them
US6482835B2 (en) Processes for producing 7-isoindoline-quinolonecarboxylic acid derivative and its intermediate, as well as salt of 7-isoindoline-quinolonecarboxylic acid derivative, its hydrate and composition comprising the same as active ingredient
CA2382265A1 (en) Prostaglandin derivatives
JP2007501800A5 (enExample)
RU2005125919A (ru) Альфа-аминоамидные производные, применимые в качестве антимигренозных средств
JP2002522385A5 (enExample)
US6646003B2 (en) Method of treating ocular inflammatory and angiogenesis-related disorders of the posterior segment of the eye using an amide derivative of flurbiprofen or ketorolac
JP2004525154A5 (enExample)
JP2005514440A5 (enExample)